We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+5.79%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$64.7B
AUM Growth
+$5.24B
Cap. Flow
+$2.36B
Cap. Flow %
3.65%
Top 10 Hldgs %
20.54%
Holding
3,821
New
235
Increased
1,962
Reduced
1,317
Closed
186

Top Sells

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$40.1M
2
T icon
AT&T
T
+$28M
3
FTXO icon
First Trust Nasdaq Bank ETF
FTXO
+$24.3M
4
TTE icon
TotalEnergies
TTE
+$23.7M
5
WMT icon
Walmart Inc
WMT
+$22.8M

Sector Composition

Rank Sector Weight
1 Technology 10.68%
2 Financials 9.21%
3 Healthcare 8.48%
4 Industrials 6.92%
5 Consumer Discretionary 5.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HWC icon
3576
CALL
Hancock Whitney
HWC
$6.22B
$5K ﹤0.01%
34,500
-100
-0.3% -$5.03K
MDLZ icon
3577
CALL
Mondelez International
MDLZ
$78.8B
$5K ﹤0.01%
+10,300
New +$439K
TECK icon
3578
CALL
Teck Resources
TECK
$32.6B
$5K ﹤0.01%
22,900
-200
-0.9% -$4.81K
AGRX
3579
DELISTED
Agile Therapeutics
AGRX
$5K ﹤0.01%
6
AMAT icon
3580
CALL
Applied Materials
AMAT
$422B
$4K ﹤0.01%
28,200
-1,200
-4% -$53.1K
GSK icon
3581
CALL
GSK
GSK
$104B
$4K ﹤0.01%
63,840
-320
-0.5% -$16.3K
IMUX icon
3582
Immunic
IMUX
$193M
$4K ﹤0.01%
33
-2
-6% -$5.22K
KSU
3583
CALL
DELISTED
Kansas City Southern
KSU
$4K ﹤0.01%
+24,000
New +$2.73M
NAVB
3584
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$4K ﹤0.01%
800
ENV
3585
PUT
DELISTED
ENVESTNET, INC.
ENV
$4K ﹤0.01%
+15,400
New +$931K
ETD icon
3586
CALL
Ethan Allen Interiors
ETD
$600M
$3K ﹤0.01%
+17,100
New +$391K
GIS icon
3587
CALL
General Mills
GIS
$19.8B
$3K ﹤0.01%
55,500
+30,700
+124% +$1.39M
SWBI icon
3588
PUT
Smith & Wesson
SWBI
$632M
$3K ﹤0.01%
+39,030
New +$353K
F icon
3589
CALL
Ford
F
$55.4B
$2K ﹤0.01%
31,200
+15,900
+104% +$159K
KGC icon
3590
CALL
Kinross Gold
KGC
$32.4B
$2K ﹤0.01%
49,000
-1,500
-3% -$4.86K
KO icon
3591
CALL
Coca-Cola
KO
$376B
$2K ﹤0.01%
+11,900
New +$544K
NGD
3592
CALL
DELISTED
New Gold Inc
NGD
$2K ﹤0.01%
51,200
SIRI icon
3593
PUT
SiriusXM
SIRI
$9.77B
$2K ﹤0.01%
2,000
-2,000
-50% -$139K
STX icon
3594
CALL
Seagate
STX
$183B
$2K ﹤0.01%
10,300
-800
-7% -$42.8K
WPRT
3595
CALL
Westport Fuel Systems
WPRT
$36.1M
$2K ﹤0.01%
3,200
XLB icon
3596
CALL
State Street Materials Select Sector SPDR ETF
XLB
$8.66B
$2K ﹤0.01%
+25,600
New +$755K
CVA
3597
CALL
DELISTED
Covanta Holding Corporation
CVA
$2K ﹤0.01%
30,300
ALL icon
3598
CALL
Allstate
ALL
$68.5B
$1K ﹤0.01%
+10,300
New +$1M
AMRN
3599
CALL
Amarin Corp
AMRN
$302M
$1K ﹤0.01%
+1,115
New +$84.2K
ANF icon
3600
PUT
Abercrombie & Fitch
ANF
$5.25B
$1K ﹤0.01%
+41,600
New +$1.01M

Similar funds

Raymond James & Associates's Q3 2018 Portfolio in Review

As of Q3 2018, Raymond James & Associates held 3,821 positions worth $64.7B, up 8.8% from $59.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates deployed $2.36B of net new capital in Q3 2018, opening 235 new positions and adding to 1,962 existing holdings. Its largest new stake was State Street Communication Services Select Sector SPDR ETF: 365,478 shares worth $17.9M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Sanofi, an estimated $40.1M trimmed.

  • Raymond James & Associates's largest Q3 2018 buy was State Street Communication Services Select Sector SPDR ETF: 365,478 shares worth $17.9M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q3 2018, an estimated $155M increase.
  • Raymond James & Associates's biggest Q3 2018 reduction was Sanofi, cutting an estimated $40.1M.
  • Raymond James & Associates fully exited Abaxis Inc in Q3 2018, selling an estimated $10.5M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $64.7B portfolio in Q3 2018.
  • Raymond James & Associates opened 235 new positions and closed 186 in Q3 2018.
  • Raymond James & Associates's portfolio value rose 8.8% quarter-over-quarter to $64.7B.

Based on Raymond James & Associates's 13F filing for Q3 2018, filed 14 Nov 2018.